Biological factors associated with depression—dysregulation of the pituitary axis and cortisol levels in the brain—may also lead to increased risk for dementia in people with depression and diabetes.Abstract Teaser ...[Read More]

• Alkermes Inc. announced in September that the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee voted 12-1 that Vivitrol (naltrexone for extended-release injectable suspension) should be approved for the treatment of opioid dependence. Though not binding, the advisory committee's recommendation will be considered in the FDA review of the ...[Read More]